🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of bimatoprost sustained-r...
Status
Completed
Location
Eye Center South
Start Date
2014-12-15
Trial ID
NCT02250651
This study was to compare the safety and efficacy of the preservative-free ...
Status
Completed
Location
Multiple Locations
Start Date
2010-01-06
Trial ID
NCT01026831
Treatments Being Tested
Evaluate the effectiveness of dorzolamide-timolol (Cosopt®) as first line t...
Status
Completed
Location
Multiple Locations
Start Date
2006-05-31
Trial ID
NCT00546286
The purpose of this study is to evaluate the additive intraocular pressure ...
Status
Terminated
Location
Contact Alcon for Locations (Europe, Asia, and Latin America)
Start Date
2016-06-24
Trial ID
NCT02730871
This study will evaluate the efficacy and safety of bimatoprost SR in parti...
Status
Completed
Location
Arizona Glaucoma Specialists
Start Date
2014-12-15
Trial ID
NCT02247804
A previous pilot study demonstrated that commonly available glaucoma drops ...
Status
Completed
Location
Palo Alto Medical Foundation
Start Date
2017-02-08
Trial ID
NCT03034772
Treatments Being Tested
The clinical study compares safety and efficacy of MK0507A (dorzolamide 1.0...
Status
Completed
Location
Multiple Locations
Start Date
2007-03-12
Trial ID
NCT00449956
This study is comparing 2 medications for glaucoma and how effective they a...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00108017
Phase III study to compare the safety and efficacy of intraocular implants ...
Status
Completed
Location
Vance Thompson Vision
Start Date
2018-07-26
Trial ID
NCT03519386
Treatments Being Tested
Phase III study to compare the safety and efficacy of intraocular implants ...
Status
Completed
Location
Center for Sight
Start Date
2018-09-17
Trial ID
NCT03868124
Treatments Being Tested